Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.45 USD
-0.13 (-4.85%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $2.44 -0.01 (-0.41%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.11 | -9.09% |
Earnings Summary
For their last quarter, Taysha Gene Therapies (TSHA) reported earnings of $0.35 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 488.89%. Look out for TSHA's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year increase of 60.71%.
Earnings History
Price & Consensus
Zacks News for TSHA
Taysha Gene Therapies, Inc. (TSHA) Just Flashed Golden Cross Signal: Do You Buy?
TSHA: What are Zacks experts saying now?
Zacks Private Portfolio Services